Microsoft will still allow LinkedIn’s rivals access to its software and give hardware makers the option of installing other services to try to win EU approval for its takeover of the US firm, people familiar with the matter said.
The US software company submitted its LinkedIn concessions to the European Commission last week after the EU competition enforcer expressed concerns about the $26 billion deal, Microsoft’s biggest ever acquisition.
The offer aims to show that Microsoft will not favor LinkedIn at the expense of rivals, the people said, in an attempt to address a key concern for regulators.
Both the Commission and Microsoft, which have not provided details of the offer, declined to comment on Monday.
The EU is now seeking feedback from rivals and customers before deciding whether to accept the concessions, demand more or open an investigation which can take up to five months. They have until Tuesday to do so. The Commission is scheduled to rule on the deal by Dec. 6.
The Commission has fined Microsoft more than 2.2 billion euros ($2.3 billion) over the past decade for various infringements, one of them being the tying of some products to its Windows operating system to stifle competition.
Full Content: Today Online
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas